| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.6 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.6 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |